Do Not Buy New York Times (Shares)

As reported by the Jacksonville Business Journal, a Barclays analyst thinks that shares of the New York Times Co. are still grossly overvalued despite their already-depressed prices.

Though the New York Times Co will receive an estimated ~$150 million for their 17.75% stake in the Boston Red Sox, even that glut of cash still doesn't do enough to stop the money-hemorrhaging.

Read the full article here (featuring more hard numbers and facts from the Barclays analyst) at the Jacksonville Business Journal.